Literature DB >> 21357784

Unexpected erythroid and cytogenetic responses after discontinuation of a short course of lenalidomide as a result of severe skin rash in a patient with 5q syndrome.

Massimo Breccia1, Laura Cannella, Roberto Latagliata, Giuseppina Loglisci, Adriano Salaroli, Michelina Santopietro, Esther N Oliva, Giuliana Alimena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21357784     DOI： 10.1200/JCO.2010.33.5083

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy.

Authors:  Pasquale Niscola; Andrea Tendas; Laura Scaramucci; Roberta Merola; Gianfranco Catalano; Paolo de Fabritiis
Journal:  Blood Res       Date:  2014-06-25

2.  Case of Stroke from Cerebral Vasculitis following Carfilzomib, Lenalidomide, and Dexamethasone Therapy in a Patient with Relapsing Multiple Myeloma.

Authors:  Deborah Osafehinti; Kaveh Zivari
Journal:  Case Rep Hematol       Date:  2019-11-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.